Literature DB >> 22076411

Neonatal intensive care unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series.

A Spiliopoulou1, G Dimitriou, E Jelastopulu, I Giannakopoulos, E D Anastassiou, Myrto Christofidou.   

Abstract

Evaluation of epidemiological trends, risk factors, and clinical outcome associated with candidemia at a neonatal intensive care unit is reported. From January 2005 to December 2009, forty candidemia cases were identified. C. albicans and C. parapsilosis were the most common species recovered (69 and 24%, respectively). All C. parapsilosis strains were susceptible to antifungals, whereas, C. albicans exhibited higher resistance rates to azoles. Low birth weight, low gestational age, presence of central lines, endotracheal intubation, total parenteral nutrition, previous use of antibiotics, steroids, previous episode(s) of bacteremia and prolonged stay in intensive care unit were common features associated with candidemia. C. albicans was most often isolated from extremely low birth weight neonates as compared to non-albicans Candida (P < 0.01). Mortality rate was 35.7% and was associated with low gestational age (P < 0.01), low birth weight (P < 0.01), and presence of renal failure (P < 0.05). Furthermore, a critical review of recent published case series is presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076411     DOI: 10.1007/s11046-011-9498-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  40 in total

Review 1.  Strategies to prevent invasive candidal infection in extremely preterm infants.

Authors:  David A Kaufman; Paolo Manzoni
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

2.  Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.

Authors:  María L Avila-Aguero; Alejandro Canas-Coto; Rolando Ulloa-Gutierrez; Marco A Caro; Braulio Alfaro; María M Paris
Journal:  Int J Infect Dis       Date:  2005-03       Impact factor: 3.623

3.  Experience with caspofungin in the treatment of persistent fungemia in neonates.

Authors:  Girija Natarajan; Mirjana Lulic-Botica; Chokechai Rongkavilit; Athina Pappas; Mary Bedard
Journal:  J Perinatol       Date:  2005-12       Impact factor: 2.521

4.  Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.

Authors:  Mohammad Asadzadeh; Noura A Al-Sweih; Suhail Ahmad; Zia U Khan
Journal:  Mycoses       Date:  2008-07       Impact factor: 4.377

5.  A first Portuguese epidemiological survey of fungaemia in a university hospital.

Authors:  S Costa-de-Oliveira; C Pina-Vaz; D Mendonça; A Gonçalves Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-19       Impact factor: 3.267

6.  Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.

Authors:  M A Ghannoum; A Chen; M Buhari; J Chandra; P K Mukherjee; D Baxa; A Golembieski; J A Vazquez
Journal:  Clin Microbiol Infect       Date:  2009-02-05       Impact factor: 8.067

7.  Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.

Authors:  Christopher C Blyth; Sharon C A Chen; Monica A Slavin; Carol Serena; Quoc Nguyen; Deborah Marriott; David Ellis; Wieland Meyer; Tania C Sorrell
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

8.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

9.  Candidemia in neonatal intensive care units: Barcelona, Spain.

Authors:  Dolors Rodriguez; Benito Almirante; Benjamin J Park; Manuel Cuenca-Estrella; Ana M Planes; Ferran Sanchez; Amadeu Gene; Mariona Xercavins; Dionisia Fontanals; Juan L Rodriguez-Tudela; David W Warnock; Albert Pahissa
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

10.  Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.

Authors:  Paolo Manzoni; Marialisa Leonessa; Paolo Galletto; Maria Agnese Latino; Riccardo Arisio; Milena Maule; Giovanni Agriesti; Luca Gastaldo; Elena Gallo; Michael Mostert; Daniele Farina
Journal:  Pediatr Infect Dis J       Date:  2008-08       Impact factor: 2.129

View more
  13 in total

Review 1.  Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature.

Authors:  Carolina M Silva; Ana M R Carvalho-Parahym; Danielle P C Macêdo; Reginaldo G Lima-Neto; Elaine C Francisco; Analy S A Melo; Maria da Conceição M Silva; Moacir B Jucá; Luciana R B Mello; Rosemary M J Amorim; Rejane P Neves
Journal:  Mycopathologia       Date:  2015-02-11       Impact factor: 2.574

2.  Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

Authors:  Maria Siopi; Aikaterini Tarpatzi; Eleni Kalogeropoulou; Sofia Damianidou; Alexandra Vasilakopoulou; Sophia Vourli; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  The role of galectin-3 in phagocytosis of Candida albicans and Candida parapsilosis by human neutrophils.

Authors:  Jennifer R Linden; Dennis Kunkel; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Cell Microbiol       Date:  2013-01-20       Impact factor: 3.715

4.  Clinical features and risk factors for blood stream infections of Candida in neonates.

Authors:  Mingyue Liu; Siyuan Huang; Linying Guo; Hongri Li; Fei Wang; Q I Zhang; Guowei Song
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

5.  Galectin-3 plays an important role in protection against disseminated candidiasis.

Authors:  Jennifer R Linden; Monique E De Paepe; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Med Mycol       Date:  2013-03-14       Impact factor: 4.076

6.  Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.

Authors:  Srisuda Pannanusorn; Bernardo Ramírez-Zavala; Heinrich Lünsdorf; Birgitta Agerberth; Joachim Morschhäuser; Ute Römling
Journal:  Eukaryot Cell       Date:  2013-12-02

7.  Antibiotic regimens for late-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Gorm Greisen; Munish Gupta; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-08

8.  Large Outbreaks of Fungal and Bacterial Bloodstream Infections in a Neonatal Unit, South Africa, 2012-2016.

Authors:  Erika van Schalkwyk; Samantha Iyaloo; Serisha D Naicker; Tsidiso G Maphanga; Ruth S Mpembe; Thokozile G Zulu; Mabatho Mhlanga; Sibongile Mahlangu; Motlatji B Maloba; Grace Ntlemo; Kgomotso Sanyane; Dini Mawela; Nelesh P Govender
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

9.  Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of Candida parapsilosis species complex.

Authors:  Mona Modiri; Seyed Jamal Hashemi; Roshanak Daie GhazvinI; Sadegh Khodavaisy; Ali Ahmadi; Mansoureh Ghaffari; Sassan Rezaie
Journal:  Curr Med Mycol       Date:  2019

10.  Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data.

Authors:  Giuseppina Caggiano; Grazia Lovero; Osvalda De Giglio; Giovanna Barbuti; Osvaldo Montagna; Nicola Laforgia; Maria Teresa Montagna
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.